Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Avista Pharma Solutions, Inc.
FDA Inspection
•Avista Pharma Solutions, Inc.•July 25, 2025

Avista Pharma Solutions, Inc. – FDA Inspection, Jul 25, 2025

Record Details

This FDA Inspection record concerns Avista Pharma Solutions, Inc., with an inspection on July 25, 2025, issued by the New England District Office, covering human drugs.

Company
Avista Pharma Solutions, Inc.
Inspection Date
July 25, 2025
Product Type
Human Drugs
Office
New England District Office
People
  • Daniel L. Zheng (FDA Associated Person)
  • Ifechimere I. Okafor (Company Rep)
View Company Profile

ID · 07d264c9-9218-4fc2-92ce-25f1f2348432

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1278383
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued, view the record

FDA Citations

5
  1. 21 CFR 211.68(b)Computer control of master formula records
  2. 21 CFR 211.56(a)Sanitation--buildings not clean, free of infestation
  3. 21 CFR 211.58Buildings not maintained in good state of repair
  4. 21 CFR 211.192Investigations of discrepancies, failures
  5. 21 CFR 211.22(d)Procedures not in writing, fully followed

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Avista Pharma Solutions, Inc.

6
DateClassificationOfficeProject area
August 14, 2026Not classifiedNew England District OfficeHuman Cellular, Tissue, and Gene Therapies
December 18, 2019VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
September 5, 2018NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
June 15, 2016VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
September 27, 2013VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 6 other inspections on the company page
Other documents for Avista Pharma Solutions, Inc.
  • FDA Inspection 1332618 - 2026-08-14
  • FDA Inspection 1113974 - 2019-12-18
  • FDA Inspection 1067530 - 2018-09-05
  • FDA Inspection 988732 - 2016-06-15
  • FDA Inspection 850250 - 2013-09-27

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Avista Pharma Solutions, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.